DaVita's (NYSE:DVA) Returns On Capital Are Heading Higher
When Should You Buy DaVita Inc. (NYSE:DVA)?
Alkermes, DaVita, Jabil, Ralph Lauren, Among Potential M&A Candidates - BofA
Deal Dispatch: Shell, Unilever And More Are On The Sell Side; The Onion Makes Alex Jones Cry Foul
Buffett's latest hold positions have been made public! Continuing to reduce shareholding in apple and silver, and these two stocks have become new favorites.
From the latest operational trends, Berkshire has newly established positions in two stocks — domino's pizza and pool supplies distributor Pool.
Berkshire Hathaway 13F Shows Increased Stake In American Express By 17% To 151.6M Shares, Now Worth $41.1B; Increased Stake In Kroger By 15% To 50M Shares, Worth $2.87B; Increased Stake In DaVita By 18%, Now Valued At $5.92B; Increased Stake In...
Golden Years For M&A Deals Ahead Under Trump? Analysts Highlight Top 10 Large-Cap Candidates
This Microcap Healthcare Stock Could Double in Value by 2027, Analyst Says
Here's Why DaVita (NYSE:DVA) Can Manage Its Debt Responsibly
DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health
DaVita Inc. to Participate in UBS Global Healthcare Conference 2024
Truist Financial Maintains DaVita(DVA.US) With Hold Rating, Announces Target Price $170
Barclays Maintains DaVita(DVA.US) With Hold Rating, Maintains Target Price $164
TD Cowen Maintains DaVita(DVA.US) With Hold Rating, Maintains Target Price $150
DaVita Is Maintained at Equal-Weight by Barclays
DaVita Analyst Ratings
UBS Adjusts Price Target on DaVita to $186 From $175, Maintains Buy Rating
US Stock Golden | Surged 240% within the year! The social platform Reddit soared over 40% after its performance, hitting a historical high; multiple bullish factors are stimulating! The US student loan giant SoFi surged over 40% in October.
1.4 billion acquisition finalized! Pharmaceutical giant abbvie acquires Alzheimer's drug company Aliada, hitting a new high after earnings last night.
Barclays Maintains DaVita(DVA.US) With Hold Rating, Raises Target Price to $164
Why DaVita Stock Withered on Wednesday